Literature DB >> 2114786

Malignant mastocytosis with circulating mast cells.

E Torrey1, K Simpson, S Wilbur, P Munoz, B Skikne.   

Abstract

A case of malignant mastocytosis with peripheral blood involvement is presented. The course of the patient's illness was complicated by recurrent hypotensive episodes, presumed to have been caused by mast cell degranulation. Treatment with hydroxyurea was associated with persistent hypotension which resulted in death. It has been proposed that the diagnosis of mast cell leukemia be given to patients presenting with greater than 10% atypical mast cells in the blood. However, review of 16 published cases of malignant mastocytosis with circulating mast cells reveals that the clinical manifestations, complications, and survival do not vary significantly with the percentage of peripheral blood mast cells. Patients with malignant mastocytosis with significant involvement by atypical mast cells in the bone marrow and peripheral blood should be considered as having an aggressive disease, regardless of the percentage of circulating mast cells.

Entities:  

Mesh:

Year:  1990        PMID: 2114786     DOI: 10.1002/ajh.2830340409

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  2 in total

1.  Detection of circulating mast cells in advanced systemic mastocytosis.

Authors:  J S Dahlin; J S Ungerstedt; J Grootens; B Sander; T Gülen; H Hägglund; G Nilsson
Journal:  Leukemia       Date:  2016-04-27       Impact factor: 11.528

2.  Prostaglandin D2-supplemented "functional eicosanoid testing and typing" assay with peripheral blood leukocytes as a new tool in the diagnosis of systemic mast cell activation disease: an explorative diagnostic study.

Authors:  Dirk Schäfer; Peter Dreßen; Stefan Brettner; Norbert-Folke Rath; Gerhard J Molderings; Katrin Jensen; Christina Ziemann
Journal:  J Transl Med       Date:  2014-08-12       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.